RUQIYA TAREEN: Open Payments
NPI 1598724122 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 21 payments from 9 companies in 2025. Trend: 2023 $95 · 2024 $1,303 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $85 |
| Lundbeck LLC | 3 | $77 |
| ABBVIE INC. | 4 | $71 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: REXULTI, NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, Qelbree, Auvelity, AUSTEDO XR, SPRAVATO, INGREZZA.
Industry payments across MI — which companies pay providers there.
